Skip to main content

Table 4 Time fixed analysis for mortality and stroke based on adherence

From: Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administration

 

Dabigatran

Rivaroxaban

HR (95% CI)

p

HR (95% CI)

p

PDC 6 month (per 0.1 decline)

1.07 (1.03–1.12)

<0.01

1.07 (0.89–1.28)

0.46

Nonadherence 6 month

1.54 (1.20–1.97)

<0.01

1.74 (0.77–3.94)

0.18

  1. Models were adjusted for demographics and comorbidities (heart failure, age, diabetes, stroke/transient ischemic attack, vascular disease, sex, coronary artery disease)
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us